Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Transplantation|June 8, 2001
Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis CJ P Ong, Z M Younossi, T Gramlich, et al.
Hospital & Community Psychiatry|February 1, 1989
A comparison of two crisis housing alternatives to psychiatric hospitalizationG R Bond, T F Witheridge, D Wasmer, et al.
Biochemical Pharmacology|January 20, 1994
Phorbol regulation of topoisomerases I and II in human leukemia cells. Studies in an additional cell pair sensitive or resistant to phorbol-induced differentiationA L Ellis, E Altschuler, E Bales, et al.
British Journal of Cancer|June 1, 1996
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposideT Asano, L A Zwelling, T An, et al.
Transplantation Proceedings|December 31, 2003
Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unitA Aggarwal, J P Ong, M Goormastic, et al.
Cancer Communications|January 1, 1990
A restriction fragment length polymorphism for human topoisomerase II: possible relationship to drug-resistanceL A Zwelling, J Mayes, K Deisseroth, et al.
International Journal of Cancer|April 1, 1991
A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistanceB T Hill, R D Whelan, L K Hosking, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejectionD Barnes, D Talenti, G Cammell, et al.
Biochemistry|April 23, 1991
Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actionsL A Zwelling, J Mayes, M Hinds, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Pageof 6